Cynata Therapeutics Secures Commitments for AU$1.5 Million Share Placement; Shares Fall 4%
MT Newswires Live
May 04
Cynata Therapeutics (ASX:CYP) received firm commitments for a placement of about 6 million ordinary shares priced at AU$0.25 each for gross proceeds of about AU$1.5 million, according to a Monday filing with the Australian bourse.
The company plans to use the proceeds for potential commercial partnerships following the release of results for its osteoarthritis and acute graft-versus-host disease clinical trials expected in May and June, respectively.
The "strategically sized" placement allows the company to bolster its cash runway beyond the readout of the results while minimizing dilution, it said.
Cynata Therapeutics shares fell 4% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.